CCL5 and plasma cell myeloma: ImiDs were identified as potent inhibitors of immunosuppressive myeloid-derived suppressor cells induction through independent downregulation of CCL5/RANTES in myeloma cells, and downregulation of a receptor for CCL5 chemokine [55].